Skip to main content
Black Rose Industries Ltd logo

Black Rose Industries Ltd — Investor Relations & Filings

Ticker · BLACKROSE ISIN · INE761G01016 LEI · 335800DXOCHG9LIZ4W64 BSE.NS Manufacturing
Open in API
Filings indexed 694 across all filing types
Latest filing 2022-03-24 Regulatory Filings
Country IN India
Listing BSE.NS BLACKROSE

About Black Rose Industries Ltd

https://www.blackrosechemicals.com

Black Rose Industries Ltd is a specialty chemical company engaged in the manufacturing and distribution of performance chemicals. The company operates a large-scale acrylamide manufacturing facility utilizing advanced biocatalytic technology to produce high-purity monomeric acrylamide. Its product portfolio includes polyacrylamides, ceramic binders, and specialty chemicals tailored for applications in water treatment, pulp and paper, textiles, and oil and gas exploration. Beyond its manufacturing operations, the company acts as a strategic distribution partner for several global chemical producers, providing technical sales and supply chain management. The company emphasizes sustainable chemical processes and maintains rigorous quality standards to serve diverse industrial sectors across domestic and international markets.

Recent filings

Filing Released Lang Actions
Intimation regarding Loss of Share Certificate
Regulatory Filings Classification · 95% confidence The document is an intimation letter to the stock exchange regarding the loss of a share certificate by a shareholder, including details of the lost certificate and a notice for claims before issuing a duplicate. It references SEBI Listing Obligations and Disclosure Requirements but does not contain financial data, earnings, management changes, or regulatory filings beyond this specific notification. The document is short (2768 characters) and is a formal notification about share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2022-03-24 English
Intimation regarding Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is an official communication addressed to the stock exchange (BSE Limited) regarding the loss of share certificates by a shareholder. It includes details such as folio number, shareholder name, number of shares, certificate numbers, and distinctive numbers. The document also contains a notice inviting claims from any person who might have a claim on the lost certificates before issuing duplicates. There is no financial data, management discussion, or report content. The document is a regulatory announcement related to share certificate loss and replacement, which does not fit into financial reports or management information categories. It is a regulatory filing informing the exchange and public about the loss of share certificates and the company's intended action. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short (2801 characters), and it is not an announcement of a report but a standalone regulatory notice.
2022-03-11 English
Issue of Duplicate Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Market Operations Department of BSE Limited regarding the issue of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content includes details of shareholders, folio numbers, share counts, and new certificate numbers. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an official notification about share certificate issuance, which fits the category of Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit into more specific categories like share issue or capital change (SHA) or director dealings (DIRS). The document length is short and it is not a report or announcement of a report publication, so it is not RPA. Therefore, the best classification is Regulatory Filings (RNS).
2022-03-10 English
Intimation regarding Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the loss of share certificates, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details about shareholders who have reported lost certificates and the company's intention to issue duplicate certificates. The document is a regulatory announcement related to share certificate loss and does not contain financial statements, management discussion, or other report content. It is not a report itself but a regulatory notification to the stock exchange and shareholders. Therefore, it fits best under Regulatory Filings (RNS). The document length is 3658 characters, which is relatively short and consistent with a regulatory filing notice rather than a full report.
2022-03-09 English
Intimation regarding Loss of Share Certificate
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding the loss of share certificates and the intention to issue duplicate certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related procedures. The content includes shareholder details, certificate numbers, and a request for claims within 15 days. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an official regulatory announcement related to share certificates but does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is a regulatory compliance filing notifying the stock exchange and shareholders about lost share certificates and the process to issue duplicates. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short and focused on regulatory compliance, not a report or announcement of a report publication.
2022-02-24 English
Commencement of commercial production of N-Methylol Acrylamide (NMA) for the information of all the stakeholders of the company.
Regulatory Filings Classification · 95% confidence The document is an announcement dated February 21, 2022, informing stakeholders about the commencement of commercial production of a product (N-Methylol Acrylamide) at the company's manufacturing facility. It references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is short (1805 characters) and serves as a notification rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed operational results. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-02-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.